A multicentric retrospective study assessing the efficacy of treatments after first-line chemotherapy
Latest Information Update: 16 Oct 2020
At a glance
- Drugs Anthracyclines (Primary) ; Bevacizumab (Primary) ; Cabozantinib (Primary) ; Gemcitabine (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary) ; Pazopanib (Primary) ; Sunitinib (Primary) ; Taxanes (Primary)
- Indications Carcinoma; Renal cell carcinoma
- Focus Therapeutic Use
- 16 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress